Skip to content

LeadershipNot yet confirmed elsewhere1 publisher2 min readPublished

Ex-Merck oncology marketing director sues over a firing during approved disability leave

Merck's former global oncology marketing director sued the company October 9, alleging a nearly three-year discrimination campaign that ended in her firing. The 12-count complaint says she was on approved disability leave after emergency bowel surgery when Merck terminated her.

The Board Room · Leadership desk

How we use AISend a correction

Illustration accompanying Ex-Merck oncology marketing director sues over a firing during approved disability leave
Generated illustration
Suit says no remote teammate faced her travel demand Figures as alleged in the complaint, reported by hcamag.com: required trips, the worker's pay and experience, and the legal claims filed.

Key figures alleged in the complaint: about 15 required trips from North Carolina to New Jersey, May to November 2023; total annual pay of approximately $300,000 to $350,000; 12 legal claims against Merck and her supervisor; 19 years of pharmaceutical experience.

Suit says no remote teammate faced her travel demand
FigureValueNoteClaim
Required trips, North Carolina to New Jersey15 trips, approx.7
Total annual compensation, approximately, at least300,000 USDup to $350,0006
Legal claims filed12 claims2
Pharmaceutical experience19 years6

What happened

  • The suit went to the US District Court for the District of New Jersey and names Merck and her direct supervisor under federal civil rights, family-leave and benefits laws plus three New Jersey statutes.
  • She joined Merck in January 2022 with 19 years of pharmaceutical experience, held a "Successful" rating under earlier managers, and earned roughly $300,000 to $350,000 a year.
  • After the new supervisor arrived in May 2023, the complaint says, he required her to fly from North Carolina to New Jersey twice a month, about 15 trips by November, a demand no other remote teammate faced.
  • Days after he emailed the team "Congratulation on the achievement," the complaint says, he rated her "Needs Improvement," the lowest of three levels, and cut her bonus in half.
  • A week after her March 8, 2024 written report of religious discrimination, an HR representative allegedly said the supervisor's management was "not done properly" and promised coaching.

Why it matters

  • exposure The counts include family leave, benefits and earned sick leave, so Merck's handling of her leave is in dispute alongside one manager's conduct.
  • constraint Any performance defense has to account for a move from "Successful" ratings under earlier managers to "Needs Improvement" under the new one.
  • exposure The complaint quotes an HR representative twice and places one in the room on August 28 without intervening, so HR files and testimony are likely to matter to the outcome.

The performance dispute runs through Merck's own paperwork. According to the complaint, the supervisor's review reproduced seven favorable colleague assessments on its first page, in the same document that gave her the failing grade [9]. The filing says an HR representative then dismissed praise from about 20 colleagues recorded in Merck's own system, saying "They are your friends they will put that to please you" [12].

Merck's Office of Ethics opened an investigation and closed it in August 2024, finding no discrimination [3]. In our view that is the company's strongest answer in the account, and it speaks only to the earlier allegations. The complaint places the supervisor's learning of the pregnancy nine days after the closure [4], so the finding predates every pregnancy allegation [5]. It also sits against the HR representative's earlier acknowledgment of a management problem [11]. Poor management is not the same finding as discrimination, and both statements appear in the complaint.

The pregnancy sequence is short. Merck's leave administrator notified the supervisor on August 27, 2024 [13]. The next day, according to the complaint, he questioned whether Merck would pay for her maternity leave, and she had to share her screen to show the policy while an HR representative in the room did not intervene [14]. On August 29 he sent a "High" importance performance write-up [15]. That is two days from the notice to the write-up [16].

In our view the sequence matters more than any one act. A closed investigation, a leave notice and a formal write-up all fall in August 2024 [c10, c12, c14], and the supervisor she had reported to HR in March issued the write-up [c7, c14]. An employer that keeps the same manager in place after closing a complaint then has to decide who reviews that manager's next adverse action.

Everything above is allegation drawn from the complaint filed October 9 [1]. The reporting available to us does not include Merck's response, the date of the termination or the reason Merck gave for it. Until Merck answers in court, the August 2024 ethics closure is the only company-side finding in the account [3].

What to watch

  • Merck's first filing in the District of New Jersey, and whether it leans on the August 2024 ethics finding.
  • Whether the individually named supervisor answers separately from the company.
  • The termination date and the stated reason, once either side pleads them.

Clarity's read

What the record supports and how the coverage leans. The claims behind it follow.

Reality

Evidence30
Adoption
Insufficient
Hype gap
Insufficient
Incentives
Insufficient
Confidence35
Why these scores

Claim ledger

Ranked by verification strength, evidence, and original report placement.

  1. [1]

    A former Global Director of Oncology Marketing filed a federal lawsuit against Merck & Co. alleging a nearly three-year campaign of religious, racial, pregnancy and disability discrimination that ended with her termination while she was on approved disability leave recovering from emergency bowel surgery.

    ReportedSupportedSource: hcamag.com, reporting on the complaintView cited source
  2. [2]

    The complaint, filed October 9, 2026, in the US District Court for the District of New Jersey, brings 12 legal claims against Merck and the worker's direct supervisor under federal civil rights, family and medical leave, and employee benefits laws, as well as New Jersey's anti-discrimination, whistleblower and earned sick leave statutes.

    ReportedSupportedSource: hcamag.com, reporting on the complaintView cited source
  3. [3]

    Merck's Office of Ethics opened an investigation and closed it in August 2024, the complaint says, finding no discrimination.

    ReportedSupportedSource: hcamag.com, reporting on the complaintView cited source

Sources

1 independent publisher whose own reporting we read for this story.

  1. hcamag.com

    1 article · October 12, 2026

    Merck worker alleges pregnancy news triggered three-year campaign to force her out

Share your take

Let Clarity write the post for you.

Signed-in readers get a short post drafted on this story in the register they choose — narrative, analytical, or a direct position — editable to the last word before it goes anywhere. The share buttons at the top of this story work without an account.

Topics and entities

Follow any of these and your For You feed starts watching them — no settings page required.

Entities

  • Merck & Co.Follow
  • U.S. District Court for the District of New JerseyFollow
Loading related stories